Monoclonal antibody therapy for COVID-19 in solid organ transplant recipients ZA Yetmar, E Beam, JC O’Horo, R Ganesh, DM Bierle, L Brumble, ... Open forum infectious diseases 8 (6), ofab255, 2021 | 67 | 2021 |
Outcomes of COVID-19 with the Mayo Clinic model of care and research JC O’Horo, JR Cerhan, EJ Cahn, PR Bauer, Z Temesgen, J Ebbert, ... Mayo Clinic Proceedings 96 (3), 601-618, 2021 | 32 | 2021 |
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch ZA Yetmar, E Beam, JC O'Horo, MT Seville, L Brumble, R Ganesh, ... Transplant Infectious Disease 24 (4), e13901, 2022 | 31 | 2022 |
The Characteristics of Capnocytophaga Infection: 10 Years of Experience S Chesdachai, DBG Tai, ZA Yetmar, A Misra, N Ough, O Abu Saleh Open Forum Infectious Diseases 8 (7), ofab175, 2021 | 31 | 2021 |
Inpatient care of patients with COVID-19: a guide for hospitalists ZA Yetmar, M Issa, S Munawar, MC Burton, V Pureza, MR Sohail, ... The American journal of medicine 133 (9), 1019-1024, 2020 | 28 | 2020 |
Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: an analysis of symptomatic cases and monoclonal antibody therapy ZA Yetmar, E Bhaimia, DM Bierle, R Ganesh, RR Razonable Transplant Infectious Disease 24 (2), e13779, 2022 | 21 | 2022 |
Outcomes of nocardiosis and treatment of disseminated infection in solid organ transplant recipients ZA Yetmar, DW Challener, MT Seville, W Bosch, E Beam Transplantation 107 (3), 782-791, 2023 | 17 | 2023 |
Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant? EJ Cano, ZA Yetmar, RR Razonable Open Forum Infectious Diseases 7 (12), ofaa527, 2020 | 16 | 2020 |
Prior statin use and risk of mortality and severe disease from coronavirus disease 2019: a systematic review and meta-analysis ZA Yetmar, S Chesdachai, T Kashour, M Riaz, DJ Gerberi, AD Badley, ... Open Forum Infectious Diseases 8 (7), ofab284, 2021 | 14 | 2021 |
Recurrent nocardiosis in solid organ transplant recipients: an evaluation of secondary prophylaxis ZA Yetmar, JW Wilson, E Beam Transplant Infectious Disease 23 (6), e13753, 2021 | 12 | 2021 |
Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplantation recipients ZA Yetmar, MJ Thoendel, W Bosch, MT Seville, WJ Hogan, E Beam Transplantation and cellular therapy 29 (3), 206. e1-206. e7, 2023 | 11 | 2023 |
Association between chronic statin use and 30-day mortality in hospitalized patients with COVID-19 ZA Yetmar, DW Challener, IM Tleyjeh, MR Sohail, JR Cerhan, AD Badley, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (2), 442-446, 2021 | 11 | 2021 |
Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia ZA Yetmar, RB Khodadadi, JR Go, S Chesdachai, OM Abu Saleh European Journal of Clinical Microbiology & Infectious Diseases 42 (4), 423-430, 2023 | 10 | 2023 |
Outcomes of B-cell-depleted patients with coronavirus disease 2019 treated with Antispike monoclonal antibodies ZA Yetmar, RB Khodadadi, MT Seville, L Brumble, JC O’Horo, R Ganesh, ... Open forum infectious diseases 9 (7), ofac204, 2022 | 10 | 2022 |
Contemporary experience of Abiotrophia, Granulicatella and Gemella bacteremia S Chesdachai, ZA Yetmar, H Tabaja, IY Comba, JR Go, DW Challener, ... Journal of Infection 84 (4), 511-517, 2022 | 10 | 2022 |
Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis ZA Yetmar, S Razi, T Nayfeh, DJ Gerberi, M Mahmood, OMA Saleh International Journal of Antimicrobial Agents 59 (1), 106486, 2022 | 10 | 2022 |
Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Spinal Epidural Abscesses C Corsini Campioli, JR Go, O Abu Saleh, D Challener, Z Yetmar, ... Open Forum Infectious Diseases 8 (3), ofab071, 2021 | 10 | 2021 |
Mortality after nocardiosis: risk factors and evaluation of disseminated infection ZA Yetmar, RB Khodadadi, S Chesdachai, JW McHugh, DW Challener, ... Open Forum Infectious Diseases 10 (8), ofad409, 2023 | 9 | 2023 |
Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case‐control study ZA Yetmar, S Chesdachai, D Duffy, BH Smith, DW Challener, MT Seville, ... Clinical Transplantation 37 (9), e15016, 2023 | 8 | 2023 |
Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis M Passerini, T Nayfeh, ZA Yetmar, J Coussement, KJ Goodlet, D Lebeaux, ... Clinical Microbiology and Infection, 2023 | 7 | 2023 |